Immunotherapy of malignant melanoma using T cell-activating microbeads
J Immunol. 2026 Aug 4;215(8):vkag191. doi: 10.1093/jimmun/vkag191. ABSTRACT Metastatic disease is the prime cause of death from many malignancies. Due to the multiple different lesions and the increased aggressiveness of the cancer cells, metastatic disease is often difficult to treat. Here, the introduction of immune checkpoint blockers (ICBs) has greatly helped to improve patients’ prognosis … Read more